| Name | Title | Contact Details |
|---|
TBH is a leading provider of behavioral health services. We specialize in the treatment of children and adults with Autism Spectrum Disorders and developmental disabilities, using the principles of Applied Behavior Analysis (ABA). TBH is proud to employ a talented staff dedicated to its mission and values, constructing a team of experienced, caring and enthusiastic individuals to coordinate the best behavior program possible for children, adults and families. Further, TBH`s collaborative efforts mean that parents, schools, agencies, Supervisors and Skills Trainers all play important roles in behavior programs, forming a large team dedicated to the needs of each client. TBH employs many Board Certified Behavior Analysts, and each Behavioral Consultant, also known as a Supervisor, is carefully screened to meet the qualifications set forth by TBH as well as those of the Behavior Analyst Certification Board (BACB). Further, each Skills Trainer, also known as a Paraprofessional, is screened using the same criteria. Behavioral Consultants and Skills Trainers are selected for clients on a case-by-case basis with careful consideration given to education, level of experience, and personality compatibility with the family and child.
Universal Rhblttion Ftnes Inst is a Livingston, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Founded in 1985, Senior Lifestyle Corporation is a family-owned company dedicated to promoting healthy, happy resident experiences through an unmatched level of service. Serving seniors at all economic levels and all levels of care, including independent living, assisted living, memory care and skilled nursing, Senior Lifestyle`s award-winning programs are recognized for their creativity and innovation in improving the lives of both residents and their families. Senior Lifestyle employs dedicated staff members who are passionate about their work and care for every resident like family.
Portola Pharmaceuticals is dedicated to developing and commercializing therapies that transform patient lives and advance patient care by changing treatment paradigms in thrombosis and other hematologic diseases. Our two lead assets are Bevyxxa® (betrixaban), and andexanet alfa. In addition, cerdulatinib is our investigational Syk/JAK inhibitor to treat hematologic cancers. These compounds come from our own internal research efforts and represent important advances to address significant unmet needs. We are employing novel strategies that may increase the likelihood of clinical, regulatory and commercial success of our potentially lifesaving therapies.
Northeast Dental is a Rochester, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.